Study on the clinical manifestations and prognosis of patients with systemic lupus erythematosus

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-11001284

Enrollment

Unknown

Registered

2011-03-28

Start date

2001-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus

Interventions

Total:renal biopsy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with signed informed consent and with good compliance; 2. Patients fulfilled the American College of Rheumatology criteria for classification of systemic lupus erythematosus.

Exclusion criteria

Exclusion criteria: Patients without signed informed consent

Design outcomes

Primary

Measure	Time frame
classes of lupus nephritis;	—

Secondary

Measure	Time frame
clinical manifestations, laboratory examinations;	—

Countries

China

Contacts

Public ContactZhu Ping

zhuping@fmmu.edu.cn+86 29 84775355

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026